Key facts
- Renais’s last known valuation is $40.8M (Jan 2025).
- It has raised $8.2M; the latest was Early Stage VC ($7.5M) in Jan 2025.
- Notable investors include InvestBev, Freedom Trail Capital, Jean-Sebastien Robicquet, Maison Villevert.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Renais
- ·The full record, as it builds
Funding rounds
No funding rounds for Renais are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Renais
Producer of alcoholic beverages intended to offer a gin inspired by French winemaking tradition. The company uses pressed grapes, kimmeridgian stone, lemon peel, linden flowers, coriander seeds, and angelica root, along with other natural ingredients to make alcoholic drinks, enabling consumers to enjoy gin as per their choice.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Poole, United Kingdom
- Founded
- 2022
- Employees
- 10
- Website
- renais.co.uk/
- Ownership
- Privately Held (backing)
Renais doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Renais shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Renais in its N-PORT filings yet. We sweep new filings monthly.